Insulin regulation of gluconeogenesis.

Autor: Hatting M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts., Tavares CDJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts., Sharabi K; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts., Rines AK; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts., Puigserver P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.
Jazyk: angličtina
Zdroj: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Jan; Vol. 1411 (1), pp. 21-35. Date of Electronic Publication: 2017 Sep 03.
DOI: 10.1111/nyas.13435
Abstrakt: The coordinated regulation between cellular glucose uptake and endogenous glucose production is indispensable for the maintenance of constant blood glucose concentrations. The liver contributes significantly to this process by altering the levels of hepatic glucose release, through controlling the processes of de novo glucose production (gluconeogenesis) and glycogen breakdown (glycogenolysis). Various nutritional and hormonal stimuli signal to alter hepatic gluconeogenic flux, and suppression of this metabolic pathway during the postprandial state can, to a significant extent, be attributed to insulin. Here, we review some of the molecular mechanisms through which insulin modulates hepatic gluconeogenesis, thus controlling glucose production by the liver to ultimately maintain normoglycemia. Various signaling pathways governed by insulin converge at the level of transcriptional regulation of the key hepatic gluconeogenic genes PCK1 and G6PC, highlighting this as one of the focal mechanisms through which gluconeogenesis is modulated. In individuals with compromised insulin signaling, such as insulin resistance in type 2 diabetes, insulin fails to suppress hepatic gluconeogenesis, even in the fed state; hence, an insight into these insulin-moderated pathways is critical for therapeutic purposes.
(© 2017 New York Academy of Sciences.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje